SCHEMBL2424142

SCHEMBL2424142

CCC(C)Nc1cc(C(=O)O)c(C)cc1C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 5/20 0.46
HSP90AB1 P08238 5/20 0.46
HCAR3 P49019 3/20 0.43
HIPK2 Q9H2X6 1/20 0.38
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 1/20 0.35
RAB9A P51151 1/20 0.35
NNMT P40261 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
GABRA4 P48169 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2426568 1.00 HSP90AA1 (0.46) HSP90AA1HSP90AB1HCAR3HIPK2KDM4E
SCHEMBL29460660 1.00 HSP90AA1 (0.46) HSP90AA1HSP90AB1HCAR3HIPK2KDM4E
SCHEMBL2424139 1.00 HSP90AA1 (0.46) HSP90AA1HSP90AB1HCAR3HIPK2KDM4E
SCHEMBL13450322 0.94 HSP90AA1 (0.47) HSP90AA1HSP90AB1HCAR3HIPK2KDM4E
SCHEMBL2422596 0.88 HSP90AA1 (0.46) HSP90AA1HSP90AB1HCAR3KDM4ENNMT
SCHEMBL2425798 0.87 HSP90AA1 (0.38) HSP90AA1HSP90AB1HCAR3KDM4EALDH1A1
SCHEMBL2426951 0.87 HSP90AA1 (0.44) HSP90AA1HSP90AB1HCAR3HIPK2KDM4E
SCHEMBL2426953 0.87 HSP90AA1 (0.44) HSP90AA1HSP90AB1HCAR3HIPK2KDM4E
SCHEMBL2424707 0.86 HSP90AA1 (0.41) HSP90AA1HSP90AB1HCAR3KDM4EALDH1A1
SCHEMBL2428783 0.85 HCAR3 (0.40) HSP90AA1HSP90AB1HCAR3HIPK2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101910168-B Tropane compounds EXELIXIS INC 2014-07-30 CN disclosed
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 US disclosed
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 US disclosed
US-8012956-B2 Tropane compounds EXELIXIS, INC. (US) 2011-09-06 US disclosed
EP-2074120-B1 TROPANE COMPOUNDS EXELIXIS INC (US) 2010-03-03 EP disclosed
EP-2074120-B1 TROPANE COMPOUNDS EXELIXIS INC (US) 2010-03-03 EP disclosed
EP-2074120-A1 TROPANE COMPOUNDS Exelixis, Inc. (US) 2009-07-01 EP disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 US disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 US disclosed
US-20090163471-A1 Tropane compounds EXELIXIS, INC. 2009-06-25 US disclosed
WO-2009055077-A1 TROPANE COMPOUNDS EXELIXIS, INC. (US) 2009-04-30 WO disclosed
WO-2009055077-A1 TROPANE COMPOUNDS EXELIXIS, INC. (US) 2009-04-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163471-A1 Tropane compounds ADRA1B, ADRA2B, ADRB2 HSP90AA1 1888/4885HSP90AB1 1352/4885HCAR3 1036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.